Mikhail Blagosklonny’s Endeavours in Eradicating Cancer

Cancer is one of the most excruciating ailments that have often paralysed various aspects of human life. Medical practitioners and scientific researchers have consequently envisaged making advancements which would give cancer a coup de grace that shall wipe it off the face of the earth. Mikhail Blagosklonny is a prototypic example of such medical stakeholders who have dedicated their careers to the medical research that seeks to combat cancer. Other than his anti-cancer endeavours, Mikhail Blagosklonny also envisions offering the available treatment to every victim regardless of their economic standing.

Mikhail Blagosklonny currently works at the Rosewell Park Cancer Institute located in Buffalo, New York as a Professor of Oncology. His insatiable desire and passion for combating cancer has enabled him to conduct immense research on myriad aspects of cancer and the requisite therapies. He holds to the belief that the life span of cancer patients can be extrapolated by the use of a drug known as Rapamycin.

In a recent publication on Philly Purge, Mikhail Blagosklonny explored the healing properties of Rapamycin, also referred to as Sirolimus or Rapamune. Rapamycin is one of the most versatile cancer drugs and bears the following properties:

It can be used in treating CancerIt also bears some Immunosuppressive properties

  • It can be used in treating Cancer: Rapamycin has some anti-proliferative properties that increase the patient’s immunity against tumours. Moreover, it mitigates the effects of cancer on the patient’s body by enhancing tumour regression. These properties make Rapamycin an essential drug in the fight against cancer.
  • It also bears some Immunosuppressive properties: It is a common phenomenon that the body rejects new transplanted organs after a surgical transplantation of organs such as Kidneys. Rapamycin comes in handy to resolve this medical problem since it inhibits such rejections, and because it has significantly low levels of toxicity.

Other than its Immunosuppressive and anti-proliferative properties that enable Rapamycin treat cancer, Mikhail Blagosklonny also explained that the drug can be used to treat patients suffering from Haemolytic-uremic Syndrome, Lymphangioleiomatosis, and Tuberous Sclerosis Complex (TSC).

Mikhail Blagosklonny’s remarkable endeavors in the cancer eradication campaign were also elaborated in a publication on Healing Magic where his plans for the Oncological realm were clearly set out. Mikhail Blagosklonny generally acknowledges that cancer is more common in elderly individuals and has consequently set out the following plans:


  • He seeks to figure out a treatment for cancer that would eradicate cancer in an effective manner that is neither costly nor physically traumatic.
  • He also envisions figuring out a treatment of cancer that would only destroy the cancerous cells without having any negative ramifications on the normal cells in the patient’s body.

Mikhail Blagosklonny’s monumental research regarding cancer gives whispers of hope to most cancer patients, and there is finally light at the end of the tunnel. His endeavours in the medical realm have often been a great inspiration to young medical practitioners who envision making the world a better place by eradicating the pandemic of cancer.